SCHEMBL994558

SCHEMBL994558

CC(N)(N)[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL851786 0.82
SCHEMBL6279283 0.75
SCHEMBL6279288 0.75
SCHEMBL794695 0.75
SCHEMBL8080119 0.72
SCHEMBL2618 0.70
Tert-Butylamine SCHEMBL760575 0.70
SCHEMBL5836531 0.68
SCHEMBL666168 0.67
SCHEMBL29017818 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023073718-A1 COSMETIC COMPOSITIONS FOR USE IN SKIN CARE GIGI COSMETIC LABORATORIES LTD (IL) 2023-05-04 WO claimed
CN-109640927-A The composition for dermal delivery comprising nano-emulsion and modified layered double hydroxide H&A帕玛科株式会社 2019-04-16 CN claimed
EP-2612654-B1 COSMETIC COMPOSITION FOR IMPROVING SKIN ELASTICITY AMOREPACIFIC CORP (KR) 2019-01-02 EP claimed
CN-108472305-A Make the increased composition of expression of peroxisome proliferation-activated receptors co-activation factor 1- α BENEBIOSIS株式会社 2018-08-31 CN claimed
EP-2612654-A2 COSMETIC COMPOSITION FOR IMPROVING SKIN ELASTICITY Amorepacific Corporation (KR) 2013-07-10 EP claimed
US-20130171274-A1 COSMETIC COMPOSITION FOR IMPROVING SKIN ELASTICITY AMOREPACIFIC CORPORATION (KR) 2013-07-04 US claimed
US-6492335-B1 Glycoconjugates from modified camptothecin derivatives (20-O-linkage) BAYER AKTIENGESELLSCHAFT (DE) 2002-12-10 US claimed
EP-0934329-B1 GLYCOCONJUGATES FROM MODIFIED CAMPTOTHECIN DERIVATES (20-O-LINKAGE) BAYER AG (DE) 2001-12-12 EP claimed
EP-0939765-B1 GLYCOCONJUGATES OF MODIFIED CAMPTOTHECIN DERIVATIVES (A- OR B-RING LINKAGE) BAYER AG (DE) 2001-12-05 EP claimed
US-6214969-B1 MODIFIED DECAPEPTPIDE; ANTITUMOR AGENTS; ANTICARCINOGENIC AGENTS THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND 2001-04-10 US claimed
US-6156754-A Glycoconjugates of modified camptothecin derivatives (A-or B-ring linkage) BAYER AKTIENGESELLSCHAFT (DE) 2000-12-05 US claimed
EP-0934329-A1 GLYCOCONJUGATES FROM MODIFIED CAMPTOTHECIN DERIVATES (20-O-LINKAGE) BAYER AG (DE) 1999-08-11 EP claimed
WO-1998015573-A1 20-O-LINKED CAMPTOTHECIN GLYCOCONJUGATES BAYER AKTIENGESELLSCHAFT (DE) 1998-04-16 WO claimed
WO-1998014459-A1 GLYCOCONJUGATES FROM MODIFIED CAMPTOTHECIN DERIVATES (20-O-LINKAGE) BAYER AKTIENGESELLSCHAFT (DE) 1998-04-09 WO claimed
EP-2850094-B1 SELF-STABILIZING LINKER CONJUGATES SEAGEN INC (US) 2024-04-17 EP disclosed
US-11957763-B2 Sulfamide linkers for use in bioconjugates SYNAFFIX B.V. (NL) 2024-04-16 US disclosed
US-20240016991-A1 CLOSED LOOP, BEDSIDE CELL PURIFICATION SYSTEMS AND METHODS LUPAGEN, INC. (US) 2024-01-18 US disclosed
EP-0219344-A1 Vinyl monomers and derived liquid crystalline polymers The University of Southern Mississippi (US) 1987-04-22 EP disclosed
US-4613658-A Vinyl monomers capable of forming side-chain liquid crystalline polymers and the resulting polymers UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 1986-09-23 US disclosed
US-3947593-A ANTIVIRUL AGENTS RICHARDSON-MERRELL INC. (US) 1976-03-30 US disclosed